P. Maingon

发表

Dentalmaps: automatic dental delineation for radiotherapy planning in head-and-neck cancer.

G. Malandain, V. Grégoire, J. Thariat, 2012, International journal of radiation oncology, biology, physics.

CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC,RTOG consensus guidelines.

K. Ang, G. Cosnard, P. Levendag, 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

CT-based delineation of organs at risk in the head and neck region: DAHANCA, EORTC, GORTEC, HKNPCSG, NCIC CTG, NCRI, NRG Oncology and TROG consensus guidelines.

R. Steenbakkers, M. V. van Herk, V. Grégoire, 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

The European Society of Therapeutic Radiology and Oncology-European Institute of Radiotherapy (ESTRO-EIR) report on 3D CT-based in-room image guidance systems: a practical and technical review and guide.

Stine Korreman, Uwe Oelfke, Dirk Verellen, 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Internal Mammary and Medial Supraclavicular Irradiation in Breast Cancer.

Laurence Collette, Rodrigo Arriagada, Erik Van Limbergen, 2015, The New England journal of medicine.

Delineation of the neck node levels for head and neck tumors: a 2013 update. DAHANCA, EORTC, HKNPCSG, NCIC CTG, NCRI, RTOG, TROG consensus guidelines.

Quynh-Thu Le, Brian O'Sullivan, Johannes A Langendijk, 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

International consensus guidelines on Clinical Target Volume delineation in rectal cancer.

Karin Haustermans, Vincenzo Valentini, Claudio Coco, 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Role of radiotherapy fractionation in head and neck cancers (MARCH): an updated meta-analysis.

M. Parmar, J. Pignon, V. Grégoire, 2017, The Lancet. Oncology.

Creating a data exchange strategy for radiotherapy research: Towards federated databases and anonymised public datasets

Andre Dekker, Uwe Just, Mechthild Krause, 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Guidelines for primary radiotherapy of patients with prostate cancer.

Michel Bolla, Raymond Miralbell, Alberto Bossi, 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Guidelines for target volume definition in post-operative radiotherapy for prostate cancer, on behalf of the EORTC Radiation Oncology Group.

Michel Bolla, Raymond Miralbell, Zvi Symon, 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Quality assurance in the 22991 EORTC ROG trial in localized prostate cancer: dummy run and individual case review.

Jean-Yves Giraud, Michel Bolla, Akos Gulyban, 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

The radiosensitization effect of titanate nanotubes as a new tool in radiation therapy for glioblastoma: a proof-of-concept.

P. Maingon, A. Papa, N. Millot, 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Ten-year survival results of a randomized trial of irradiation of internal mammary nodes after mastectomy.

R. Écochard, P. Maingon, P. Romestaing, 2013, International journal of radiation oncology, biology, physics.

Radiotherapy for head and neck cancers including chemoradiotherapy.

I. Barillot, J. Horiot, P. Maingon, 1994, Current opinion in oncology.

Evaluation of a 36 Gy elective node irradiation dose in anal cancer.

J. Bosset, P. Maingon, Stefano Kim, 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Surface markers in adult acute myeloblastic leukemia: correlation of CD19+, CD34+ and CD14+/DR--phenotypes with shorter survival. Groupe d'Etude Immunologique des Leucémies (GEIL).

E. Solary, P. Maingon, M. Béné, 1992, Leukemia.

RILA blood biomarker as a predictor of radiation-induced sarcoma in a matched cohort study☆

F. Collin, P. Maingon, J. Thariat, 2019, EBioMedicine.

Patient safety in external beam radiotherapy, results of the ACCIRAD project: Recommendations for radiotherapy institutions and national authorities on assessing risks and analysing adverse error-events and near misses.

J. Malicki, P. Maingon, M. Krengli, 2018, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

What is the clinical benefit of preoperative chemoradiotherapy with 5FU/leucovorin for T3-4 rectal cancer in a pooled analysis of EORTC 22921 and FFCD 9203 trials: surrogacy in question?

L. Collette, G. Calais, T. Conroy, 2012, European journal of cancer.

Chemotherapy: Concurrent Delivery with Radiation Therapy

J. Bosset, P. Maingon, C. Borg, 2010 .

Improved sphincter preservation in low rectal cancer with high-dose preoperative radiotherapy: the lyon R96-02 randomized trial.

P. Adeleine, P. Maingon, P. Romestaing, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Preoperative radiation (Preop RT) in rectal cancer: Effect and timing of additional chemotherapy (CT) 5-year results of the EORTC 22921 trial

L. Collette, G. Calais, J. Bosset, 2005 .

6LBA The benefit of regional irradiation in stage I–III breast cancer: 10 years results of the EORTC ROG and BCG phase III trial 22922/10925

H. Bartelink, V. Budach, P. Maingon, 2014 .

Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of the 2000-01 FFCD/SFRO study.

B. Chauffert, J. Bosset, P. Maingon, 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

Concomitant chemoradiotherapy versus acceleration of radiotherapy with or without concomitant chemotherapy in locally advanced head and neck carcinoma (GORTEC 99-02): an open-label phase 3 randomised trial.

V. Grégoire, G. Calais, J. Bourhis, 2012, The Lancet. Oncology.

A Risk Score for Predicting Death in Chagas' Heart Disease

L. Collette, J. Bosset, P. Maingon, 2006 .

[Dose constraints to organs at risk for conformational and stereotactic radiotherapy: Small bowel and duodenum].

P. Maingon, J. Castelli, E. Chajon, 2017, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Pattern of occult nodal relapse diagnosed with (18)F-fluoro-choline PET/CT in prostate cancer patients with biochemical failure after prostate-only radiotherapy.

J. Bosset, P. Maingon, F. Brunotte, 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

A survey on staging and treatment in uterine cervical carcinoma in the Radiotherapy Cooperative Group of the European Organization for Research and Treatment of Cancer.

P. Coucke, P. Maingon, I. Ciernik, 2000, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Impact on treatment outcome and late effects of customized treatment planning in cervix carcinomas: baseline results to compare new strategies.

I. Barillot, J. Horiot, P. Maingon, 2000, International journal of radiation oncology, biology, physics.

Preoperative radiochemotherapy for resectable localised oesophageal cancer: a controversial strategy.

B. Chauffert, P. Maingon, F. Ghiringhelli, 2010, Critical reviews in oncology/hematology.

Quality assurance standards drive improvements in the profile of radiation therapy departments participating in trials of the EORTC Radiation Oncology Group.

P. Maingon, A. Monti, C. Hurkmans, 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Prognostic Factors for Local Control in Breast Cancer After Long-term Follow-up in the EORTC Boost vs No Boost Trial: A Randomized Clinical Trial

E. van Limbergen, H. Bartelink, J. Horiot, 2017, JAMA oncology.

Exclusive radiotherapy for non-small cell lung cancer. A retrospective multicentric study

P. Houtte, J. Bosset, P. Maingon, 2003 .

OC-0523: Lymph node RT improves survival in breast cancer: 10 years results of the EORTC ROG and BCG phase III trial 22922/10925.

H. Bartelink, V. Budach, P. Maingon, 2014 .

Long-term quality of life in patients with rectal cancer treated with preoperative (chemo)-radiotherapy within a randomized trial.

G. Calais, J. Bosset, P. Maingon, 2010, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Maximum and mean bladder dose defined from ultrasonography. Comparison with the ICRU reference in gynaecological brachytherapy.

I. Barillot, J. Horiot, P. Maingon, 1994, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Late neointimal tissue growth behind the stent after intravascular γ-radiation☆

I. Barillot, P. Maingon, L. Rochette, 2004 .

Intramural neovascularization and haemorrhages are major long‐term effects of intravascular γ‐radiation after stenting

I. Barillot, A. Lalande, P. Maingon, 2003, International journal of radiation biology.

The role of telomeres in predicting individual radiosensitivity of patients with cancer in the era of personalized radiotherapy.

P. Maingon, R. Boidot, F. Ghiringhelli, 2015, Cancer treatment reviews.

International expert consensus statement regarding radiotherapy treatment options for rectal cancer during the COVID 19 pandemic☆

K. Spindler, K. Haustermans, C. Marijnen, 2020, Radiotherapy and Oncology.

An analysis of preoperative chemoradiotherapy with 5FU/leucovorin for T3-4 rectal cancer on survival in a pooled analysis of EORTC 22921 and FFCD 9203 trials: Surrogacy in question?

L. Collette, G. Calais, T. Conroy, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Changes in the practice of adjuvant radiotherapy in resectable rectal cancer within a French well-defined population.

C. Faivre-Finn, J. Faivre, P. Maingon, 2000, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Rectal Cancer: The Radiation Oncologist: The Great Watchmaker.

P. Maingon, F. Huguet, 2016, Seminars in radiation oncology.

Hepatic tumours and radiotherapy.

P. Maingon, F. Mornex, L. Parent, 2021, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Syddansk Universitet Role of radiotherapy fractionation in head and neck cancers ( MARCH ) an updated meta-analysis

M. Parmar, J. Pignon, V. Grégoire, 2017 .

Does the addition of chemotherapy (CT) to preoperative radiotherapy (preopRT) increase the pathological response in patients with resected rectal cancer : Report of the 22921 EORTC phase III trial.

L. Collette, G. Calais, J. Bosset, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Impact of waiting time on nodal staging in head and neck squamous-cell carcinoma treated with radical intensity modulated radiotherapy

P. Maingon, A. Bertaut, G. Créhange, 2016, Clinical and translational radiation oncology.

Treatment Strategy for Distant Synchronous Metastatic Head and Neck Squamous Cell Carcinoma

P. Maingon, S. Albert, N. Meillan, 2019, Current Oncology Reports.

[Radiochemotherapy for esophageal cancer: which nodes should be irradiated?].

P. Maingon, G. Créhange, M. Quivrin, 2014, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Cancer de l'endomètre de stade I

P. Maingon, G. Créhange, G. Truc, 2008 .

Preoperative radiotherapy and surgery for endometrial carcinoma: prognostic significance of the sterilization of the specimen.

I. Barillot, F. Collin, J. Horiot, 1998, International journal of radiation oncology, biology, physics.

Phase II Study of a Platinum-Based Adapted Chemotherapy Regimen Combined with Radiotherapy in Patients 75 Years and Older with Esophageal Cancer

J. Bosset, P. Maingon, M. Puyraveau, 2015, Drugs & Aging.

J. Thariat, P. Maingon, A. Bertaut, 2022, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

RADIATION PROTECTION N ° 181 General guidelines on risk management in external beam radiotherapy

J. Malicki, P. Maingon, H. Järvinen, 2015 .

Absolute volume of the rectum and AUC from rectal DVH between 25Gy and 50Gy predict acute gastrointestinal toxicity with IG-IMRT in prostate cancer

P. Maingon, P. Walker, G. Créhange, 2016, Radiation oncology.

Tumor Volume as Outcome Determinant in Patients Treated With Chemoradiation for Locally Advanced Esophageal Cancer

J. Bosset, P. Maingon, J. Dumas, 2006, American journal of clinical oncology.

Randomized phase III trial (GORTEC 98-03) comparing re-irradiation plus chemotherapy versus methotrexate in patients with recurrent or a second primary head and neck squamous cell carcinoma, treated with a palliative intent.

G. Calais, J. Bourhis, P. Maingon, 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Results of EORTC phase III trial 22931 comparing, postoperatively, radiotherapy (RT) to concurrent chemo-radiotherapy (RT-CT) with high dose cisplatin in locally advanced head and neck (H&N) carcinomas (SCC)

V. Budach, M. Glabbeke, M. Bolla, 2001 .

Impact of intensity-modulated radiotherapy on health-related quality of life for head and neck cancer patients: matched-pair comparison with conventional radiotherapy.

J. Bourhis, P. Giraud, P. Maingon, 2007, International journal of radiation oncology, biology, physics.

Radiotherapy in the treatment of mucosal melanoma of the upper aerodigestive tract: analysis of 74 cases. A Rare Cancer Network study.

R. Mirimanoff, M. Amichetti, P. Maingon, 2006, International journal of radiation oncology, biology, physics.

Conformal radiotherapy, reduced boost volume, hyperfractionated radiotherapy, and online quality control in standard-risk medulloblastoma without chemotherapy: results of the French M-SFOP 98 protocol.

J. Grill, P. Maingon, J. Habrand, 2003, International journal of radiation oncology, biology, physics.

Phase III randomized French multicentric study to evaluate the impact of a localized 16-Gy boost after conservative surgery and a 50-Gy whole-breast irradiation in breast ductal carcinoma in situ (the BONBIS trial).

P. Maingon, D. Cowen, C. Bourgier, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Patient safety in external beam radiotherapy, results of the ACCIRAD project: Current status of proactive risk assessment, reactive analysis of events, and reporting and learning systems in Europe.

J. Malicki, P. Maingon, M. Krengli, 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Randomized Trial Assessing the Impact of Routine Assessment of Health-Related Quality of Life in Patients with Head and Neck Cancer

P. Maingon, F. Bonnetain, S. Maillard, 2021, Cancers.

[Locally advanced unresectable pancreatic cancer: Induction chemoradiotherapy followed by maintenance gemcitabine versus gemcitabine alone: Definitive results of the 2000-2001 FFCD/SFRO phase III trial].

B. Chauffert, P. Maingon, P. Rougier, 2011, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Gemcitabine plus cisplatin versus chemoradiotherapy in locally advanced biliary tract cancer: Fédération Francophone de Cancérologie Digestive 9902 phase II randomised study.

B. Chauffert, C. Lepage, P. Maingon, 2014, European journal of cancer.

Tailored Strategy for Locally Advanced Rectal Carcinoma (GRECCAR 4): Long-term Results From a Multicenter, Randomized, Open-Label, Phase II Trial

S. Nougaret, P. Rouanet, P. Maingon, 2021, Diseases of the colon and rectum.

Primary carcinoma of the gallbladder. Adjuvant postoperative external irradiation

S. Schraub, J. Bosset, P. Maingon, 1989, Cancer.

Local Failure Events in Prostate Cancer Treated with Radiotherapy: A Pooled Analysis of 18 Randomized Trials from the Meta-analysis of Randomized Trials in Cancer of the Prostate Consortium (LEVIATHAN).

Christopher U. Jones, A. Kishan, M. Sydes, 2022, European urology.

Tailored Treatment Strategy for Locally Advanced Rectal Carcinoma Based on the Tumor Response to Induction Chemotherapy: Preliminary Results of the French Phase II Multicenter GRECCAR4 Trial

S. Nougaret, P. Rouanet, P. Maingon, 2017, Diseases of the colon and rectum.

Radiotherapy and androgen deprivation for prostate cancer.

M. Bolla, P. Maingon, G. Créhange, 2011, The New England journal of medicine.

Treatment of T1-T2 rectal tumors by contact therapy and interstitial brachytherapy.

I. Barillot, J. Horiot, P. Maingon, 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Exclusive chemoradiotherapy for patients with medically inoperable early-stage oesophageal cancer.

J. Bosset, P. Maingon, G. Créhange, 2007, Clinical oncology (Royal College of Radiologists (Great Britain)).

Association of Gleason Grade With Androgen Deprivation Therapy Duration and Survival Outcomes: A Systematic Review and Patient-Level Meta-analysis

A. Kishan, L. Collette, T. D. de Reijke, 2019, JAMA oncology.

Very accelerated radiotherapy or concurrent chemoradiotherapy for N3 head and neck squamous cell carcinoma: Pooled analysis of two GORTEC randomized trials.

V. Grégoire, G. Calais, J. Bourhis, 2017, Oral oncology.

Radiotherapy for nasopharyngeal cancer.

P. Maingon, M. Biston, F. Huguet, 2021, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Effects of combined irradiation and doxorubicin treatment on cardiac function and antioxidant defenses in the rat.

J. Horiot, P. Maingon, L. Rochette, 1999, Free radical biology & medicine.

Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial.

E. van Limbergen, H. Bartelink, J. Horiot, 2015, The Lancet. Oncology.

Induction Chemotherapy Followed by Cetuximab Radiotherapy Is Not Superior to Concurrent Chemoradiotherapy for Head and Neck Carcinomas: Results of the GORTEC 2007-02 Phase III Randomized Trial.

J. Bourhis, E. Babin, C. Borel, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Radiotherapy for laryngeal cancers.

P. Maingon, J. Biau, M. Lapeyre, 2021, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Intravascular Radiation and Stenting: Absence of Efficacy on Intimal Proliferation in a Rabbit Model

I. Barillot, J. Horiot, G. Michalowicz, 2000, Cardiovascular Drugs and Therapy.

Temozolomide and radiotherapy antitumor efficacy evaluation with magnetic resonance imaging and proton magnetic resonance spectroscopy in human glioma models in nude rats

P. Maingon, P. Walker, O. Duchamp, 2008 .

Cervical and vaginal cancer associated with pessary use

J. Horiot, S. Schraub, P. Maingon, 1992, Cancer.

[What to do with a rising PSA after complete remission post-prostatectomy?].

J. Bosset, P. Maingon, M. Bosset, 2006, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

[Radiotherapy for nasopharyngeal carcinoma].

F. Bidault, P. Maingon, P. Blanchard, 2016, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Recommendations for postoperative radiotherapy in head & neck squamous cell carcinoma in the presence of flaps: a GORTEC internationally-reviewed HNCIG-endorsed consensus.

V. Grégoire, S. Yom, M. Chua, 2021, Radiotherapy and Oncology.

Osteosarcomas of the mandible: multidisciplinary management of a rare tumor of the young adult a cooperative study of the GSF-GETO, Rare Cancer Network, GETTEC/REFCOR and SFCE.

S. Salas, A. Italiano, J. Thariat, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer.

Jacques Bernier, Michel Bolla, Mahmut Ozsahin, 2004, The New England journal of medicine.

Target volume selection and delineation (T and N) for primary radiation treatment of oral cavity, oropharyngeal, hypopharyngeal and laryngeal squamous cell carcinoma.

V. Grégoire, P. Maingon, C. Grau, 2018, Oral oncology.

Feasibility of chemoradiotherapy for oesophageal cancer in elderly patients aged >or=75 years: a prospective, single-arm phase II study.

J. Bosset, P. Maingon, M. Puyraveau, 2009, Drugs & aging.

Positron emission tomography with [18F]fluorodeoxyglucose improves staging and patient management in patients with head and neck squamous cell carcinoma: a multicenter prospective study.

Vincent Grégoire, Hervé Reychler, Max Lonneux, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Patients with curative resection of cT3-4 rectal cancer after preoperative radiotherapy or radiochemotherapy: does anybody benefit from adjuvant fluorouracil-based chemotherapy? A trial of the European Organisation for Research and Treatment of Cancer Radiation Oncology Group.

M. Piérart, L. Collette, G. Calais, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Conservative management of rectal adenocarcinoma by radiotherapy.

I. Barillot, J. Horiot, P. Maingon, 1998, International journal of radiation oncology, biology, physics.

Enhanced tumorocidal effect of chemotherapy with preoperative radiotherapy for rectal cancer: preliminary results--EORTC 22921.

Laurence Collette, Gilles Calais, L. Collette, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Chemotherapy with preoperative radiotherapy in rectal cancer.

Laurence Collette, Gilles Calais, L. Collette, 2006, The New England journal of medicine.

Genomic and transcriptomic comparison of post-radiation versus sporadic sarcomas

F. Collin, F. Chibon, Gaëlle Pérot, 2019, Modern Pathology.

Multidisciplinary Rectal Cancer Management: 2nd European Rectal Cancer Consensus Conference (EURECA-CC2).

J. Borrás, L. Påhlman, K. Haustermans, 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Preoperative chemoradiotherapy versus preoperative radiotherapy in rectal cancer patients: assessment of acute toxicity and treatment compliance. Report of the 22921 randomised trial conducted by the EORTC Radiotherapy Group.

M. Piérart, G. Calais, J. Bosset, 2004, European journal of cancer.

Androgen deprivation therapy use and duration with definitive radiotherapy for localised prostate cancer: an individual patient data meta-analysis.

A. Kishan, T. D. de Reijke, H. Sandler, 2022, The Lancet. Oncology.

Role of radiation therapy in the treatment of primary tracheal carcinoma.

P. van Houtte, P. Maingon, F. Mornex, 1998, International journal of radiation oncology, biology, physics.

Stereotactic body radiation therapy for liver tumors.

P. Maingon, F. Mornex, G. Créhange, 2014, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

[Primary liver cancer].

James V. Leonard, A. L. Wong, I. Módy, 1989, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

[Nasal cavity and paranasal sinus cancer].

P. Giraud, P. Maingon, C. Lafond, 2016, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Male breast cancer. Evolution of treatment and prognostic factors. Analysis of 489 cases.

F. Penault-Llorca, P. Maingon, P. Romestaing, 2010, Critical reviews in oncology/hematology.

Exclusive image guided IMRT vs. radical prostatectomy followed by postoperative IMRT for localized prostate cancer: a matched-pair analysis based on risk-groups

P. Maingon, G. Créhange, M. Gauthier, 2012, Radiation oncology.

[White paper on radiation oncology in France. Twelve proposals to improve a major cancer treatment. Société française de radiothérapie oncologique].

I. Barillot, J. Ferlay, C. de Martel, 2013, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Management and work-up procedures of patients with head and neck malignancies treated by radiation.

P. Maingon, L. Vieillevigne, Y. Pointreau, 2021, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Safety and efficacy of intensity-modulated radiotherapy in the management of spermatic cord sarcoma.

P. Maingon, G. Créhange, G. Truc, 2017, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

High dose rate brachytherapy for superficial cancer of the esophagus.

I. Barillot, J. Horiot, P. Maingon, 2000, International journal of radiation oncology, biology, physics.

Primary uncommon tumours of the lung: lymphomas, sarcomas and melanomas

P. Maingon, K. Peignaux, 2009 .

Primary breast lymphoma: Patient profile, outcome and prognostic factors. A multicentre Rare Cancer Network study

R. Mirimanoff, A. Taghian, P. Scalliet, 2008, BMC Cancer.

Outcome and prognostic factors in orbital lymphoma: a Rare Cancer Network study on 90 consecutive patients treated with radiotherapy.

S. Marnitz, R. Mirimanoff, R. Miralbell, 2003, International Journal of Radiation Oncology, Biology, Physics.

Conservative treatment of early glottic carcinomas with exclusive radiotherapy.

I. Barillot, J. Horiot, J. Thariat, 2004, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Radiotherapy of non-tumoral refractory neurological pathologies.

P. Maingon, N. Reyns, P. Maingon, 2020, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Concurrent and adjuvant docetaxel with three-dimensional conformal radiation therapy plus androgen deprivation for high-risk prostate cancer: preliminary results of a multicentre phase II trial.

M. Bolla, P. Maingon, J. Ferrero, 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Online quality control, hyperfractionated radiotherapy alone and reduced boost volume for standard risk medulloblastoma: long-term results of MSFOP 98.

D. Figarella-Branger, J. Grill, P. Maingon, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Short Androgen Suppression and Radiation Dose Escalation for Intermediate- and High-Risk Localized Prostate Cancer: Results of EORTC Trial 22991.

L. Collette, M. Bolla, J. Bosset, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Radiotherapy of advanced mycosis fungoides: indications and results of total skin electron beam and photon beam irradiation.

I. Barillot, J. Horiot, T. Petrella, 2000, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

EORTC Radiation Oncology Group: 50 years of continuous accomplishments

H. Bartelink, J. Horiot, L. Collette, 2012 .

Phase III trial of protracted compared with split-course chemoradiation for esophageal carcinoma: Federation Francophone de Cancerologie Digestive 9102.

P. Maingon, F. Bonnetain, X. Mirabel, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Does gap-free intensity modulated chemoradiation therapy provide a greater clinical benefit than 3D conformal chemoradiation in patients with anal cancer?

P. Maingon, S. Dewas, G. Créhange, 2012, Radiation oncology.

Pooled Analysis of external-beam RADiotherapy parameters in phase II and phase III trials in radiochemotherapy in Anal Cancer (PARADAC).

L. Collette, J. Ajani, K. Haustermans, 2019, European journal of cancer.

Does gap-free intensity modulated chemoradiation therapy provide a greater clinical benefit than 3D conformal chemoradiation in patients with anal cancer?

P. Maingon, S. Dewas, G. Créhange, 2012, Radiation Oncology.

Adjuvant treatments for gastric cancer: from practice guidelines to clinical practice.

C. Lepage, J. Faivre, P. Maingon, 2014, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Impact of neoadjuvant chemotherapy on survival in breast cancer patients in daily practice: a population-based study.

P. Maingon, P. Arveux, P. Fumoleau, 2013, European journal of cancer care.

EORTC-ROG expert opinion: radiotherapy volume and treatment guidelines for neoadjuvant radiation of adenocarcinomas of the gastroesophageal junction and the stomach.

L. Collette, K. Haustermans, A. Kuten, 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

The FREGAT biobank: a clinico-biological database dedicated to esophageal and gastric cancers

S. Msika, T. Conroy, M. Copin, 2018, BMC Cancer.

A dose escalation study with intensity modulated radiation therapy (IMRT) in T2N0, T2N1, T3N0 squamous cell carcinomas (SCC) of the oropharynx, larynx and hypopharynx using a simultaneous integrated boost (SIB) approach.

V. Grégoire, G. Calais, P. Maingon, 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[Intensity modulated radiation therapy for head and neck cancer: The standard].

P. Maingon, G. Créhange, G. Truc, 2011, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Radiothérapie conformationnelle par modulation d’intensité

P. Maingon, G. Créhange, V. Marchesi, 2010 .

[Radiotherapy of hypopharynx cancers].

G. Calais, P. Giraud, P. Maingon, 2016, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Intensity modulated radiation therapy in head and neck squamous cell carcinoma: state of the art and future challenges.

V. Grégoire, P. Maingon, 2005, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Intensity-modulated radiation therapy in head and neck squamous cell carcinoma: an adaptation of 2-dimensional concepts or a reconsideration of current clinical practice.

V. Grégoire, P. Maingon, 2004, Seminars in radiation oncology.

Patterns of Failure in Patients With Head and Neck Squamous Cell Carcinomas of Unknown Primary Treated With Chemoradiotherapy

P. Maingon, J. Daoud, A. Bertaut, 2020, Technology in cancer research & treatment.

[Radiotherapy of larynx cancers].

G. Calais, P. Giraud, P. Maingon, 2016, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Impact of target volumes and radiation technique on loco-regional control and survival for patients with unilateral cervical lymph node metastases from an unknown primary.

P. Maingon, P. Pommier, G. Créhange, 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Improved Outcome by Adding Concurrent Chemotherapy to Cetuximab and Radiotherapy for Locally Advanced Head and Neck Carcinomas: Results of the GORTEC 2007-01 Phase III Randomized Trial.

J. Bourhis, C. Borel, P. Maingon, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

New challenge of developing combined radio-drug therapy.

V. Grégoire, P. Maingon, E. Shash, 2014, Chinese clinical oncology.

Focal or whole-gland salvage prostate brachytherapy with iodine seeds with or without a rectal spacer for postradiotherapy local failure: How best to spare the rectum?

P. Maingon, A. Bertaut, G. Créhange, 2016, Brachytherapy.

Conservative and curative management of rectal adenocarcinomas by local radiotherapy alone.

J. Horiot, P. Maingon, J. Gérard, 1995, European journal of cancer.

Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study.

L. Collette, G. Calais, M. Bolla, 2014, The Lancet. Oncology.

ESTRO-ACROP recommendations for evidence-based use of androgen deprivation therapy in combination with external-beam radiotherapy in prostate cancer.

T. Wiegel, M. Mason, C. Belka, 2023, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

High-dose Radiotherapy or Androgen Deprivation Therapy (HEAT) as Treatment Intensification for Localized Prostate Cancer: An Individual Patient-data Network Meta-analysis from the MARCAP Consortium.

A. Kishan, M. Sydes, D. Dearnaley, 2022, European urology.

Tumor volume and metabolism of prostate cancer determined by proton magnetic resonance spectroscopic imaging at 3T without endorectal coil reveal potential clinical implications in the context of radiation oncology.

Gilles Créhange, Alexandre Cochet, Paul M Walker, 2011, International journal of radiation oncology, biology, physics.

Pathological response and safety of two neoadjuvant strategies with bevacizumab in MRI-defined locally advanced T3 resectable rectal cancer: a randomized, noncomparative phase II study.

J. Bosset, P. Maingon, C. Borg, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Focal HIFU for prostate cancer.

P. Maingon, D. Peiffert, D. Azria, 2012, The Lancet. Oncology.

Impact of p16 expression on induction taxotere-cisplatin-5 FU (TPF) followed by cetuximab-radiotherapy in N2b-N3 head and neck squamous cell carcinoma (HNSCC): Results of GORTEC 2007-02 phase III randomized trial.

J. Bourhis, E. Babin, P. Maingon, 2017 .

Predictive value of health-related quality of life on radiotherapy-related toxicities in patients with head and neck cancer

P. Maingon, F. Bonnetain, S. Maillard, 2022, Supportive Care in Cancer.

Ultimate results of radiation therapy for T1-T2 mycosis fungoides (including reirradiation).

I. Barillot, J. Horiot, T. Petrella, 2004, International journal of radiation oncology, biology, physics.

Local Failure and Survival After Definitive Radiotherapy for Aggressive Prostate Cancer: An Individual Patient-level Meta-analysis of Six Randomized Trials.

A. Kishan, L. Collette, P. Boutros, 2019, European Urology.

Correlation between radio-induced lymphocyte apoptosis measurements obtained from two French centres.

P. Maingon, J. Merlin, D. Azria, 2016, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

P3 The impact of intensity-modulated radiotherapy on health-related quality of life for head and neck cancer patients. Matched-pair comparison with conventional radiotherapy

J. Bourhis, P. Giraud, P. Maingon, 2007 .

Image-guided IMRT for localized prostate cancer with daily repositioning: inferring the difference between planned dose and delivered dose distribution.

P. Maingon, A. Arnaud, F. Bonnetain, 2014, Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics.

Intensity-modulated radiation therapy

S. Webb, P. Maingon, G. Créhange, 2019, Radiopaedia.org.

Early choline levels from 3-tesla MR spectroscopy after exclusive radiation therapy in patients with clinically localized prostate cancer are predictive of plasmatic levels of PSA at 1 year.

Alexandre Cochet, Franck Bonnetain, P. Maingon, 2011, International journal of radiation oncology, biology, physics.

[Stage I endometrial carcinoma].

P. Maingon, G. Créhange, G. Truc, 2008, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Clinical assessment of the use of the Sonarray system for daily prostate localization.

I. Barillot, P. Maingon, G. Créhange, 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[High precision radiotherapy with ultrasonic imaging guidance].

I. Barillot, P. Maingon, G. Créhange, 2006, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Preoperative radiotherapy in stage I/II endometrial adenocarcinoma.

I. Barillot, F. Collin, J. Horiot, 1996, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

OC-0522: 3D-CRT/IMRT with/without short term androgen deprivation in localized T1b-cT2aN0M0 prostate cancer (EORTC 22991)

L. Collette, M. Bolla, A.C.M. van den Bergh, 2014 .

Preoperative radiochemotherapy in rectal cancer: long-term results of a phase II trial.

J. Horiot, J. Bosset, P. Maingon, 2000, International journal of radiation oncology, biology, physics.

Mapping of failures after radiochemotherapy in patients with non-metastatic esophageal cancer: A posteriori analysis of the dose distribution in the sites of loco-regional relapse.

J. Bosset, P. Maingon, Y. Petegnief, 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[Irradiation in stereotactic conditions: prerequisites].

P. Maingon, A. Lisbona, 2014, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Intensity-modulated radiation therapy in head and neck cancer: prescribed dose, clinical challenges and results.

P. Maingon, F. Bonnetain, G. Créhange, 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Effect of in vivo heart irradiation on coronary reactivity in the rat.

P. Maingon, L. Rochette, M. Benderitter, 2003, Cellular and Molecular Biology.

Outcome impact and cost-effectiveness of quality assurance for radiotherapy planned for the EORTC 22071-24071 prospective study for head and neck cancer.

V. Grégoire, C. Combescure, L. Peters, 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Multiparametric MRI and post implant CT-based dosimetry after prostate brachytherapy with iodine seeds: The higher the dose to the dominant index lesion, the lower the PSA bounce.

R. Loffroy, P. Maingon, A. Bertaut, 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[Ductal carcinoma in situ: role of the boost].

I. Barillot, P. Maingon, A. Monnier, 2008, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

6N Irradiation of the internal mammary and medial supraclavicular lymph node chain in stage I to III breast cancer: state of the day of EORTC phase III trial 22922/10925 with 4004 patients

H. Bartelink, L. Collette, V. Budach, 2010 .

Combining Sirolimus-eluting Stents and External Irradiation in Cholesterol-fed Rabbits Increased Incomplete Stent Apposition and Decreased Re-endothelialization

G. Rioufol, P. Maingon, L. Rochette, 2009, Journal of cardiovascular pharmacology.

SP-0373: Sphincter preservation in anal cancer: The EORTC PARADAC study

K. Haustermans, J. Bosset, P. Maingon, 2013 .

Accelerated versus Conventional Radiotherapy with Concomitant Chemotherapy in Locally Advanced Head and Neck Carcinomas: Results of a Phase III Randomized Trial

V. Grégoire, G. Calais, J. Bourhis, 2008 .

Preoperative radiotherapy in elderly patients with rectal cancer.

J. Bosset, P. Maingon, M. Puyraveau, 2007, Gastroenterologie clinique et biologique.

Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer.

M. van Glabbeke, J. Bourhis, M. Bolla, 2004, The New England journal of medicine.

[Quality of life for patients treated for head and neck carcinoma].

P. Maingon, F. Bonnetain, P. Romanet, 2010, Cancer Radiothérapie.

Pattern of occult nodal relapse diagnosed with 18F fluoro-choline PET/CT in prostate cancer patients with biochemical failure after prostate-only radiotherapy.

J. Bosset, P. Maingon, F. Brunotte, 2014 .

Cancer de la prostate

L. Salomon, A. Villers, P. Maingon, 2007 .

Exclusive image guided IMRT vs. radical prostatectomy followed by postoperative IMRT for localized prostate cancer: a matched-pair analysis based on risk-groups

P. Maingon, G. Créhange, M. Gauthier, 2012, Radiation oncology.

Stereotactic Body radiation therapy for liver tumors with or without rotational intensity modulated radiation therapy

P. Maingon, L. Mineur, Robin García, 2013, BMC Research Notes.

Neoadjuvant therapy for breast cancer has no benefits on overall survival or on the mastectomy rate in routine clinical practice. A population-based study with a median follow-up of 11 years using propensity score matching.

P. Maingon, P. Arveux, P. Fumoleau, 2012, European journal of cancer.

Clinical impact of margin reduction on late toxicity and short-term biochemical control for patients treated with daily on-line image guided IMRT for prostate cancer.

Franck Bonnetain, P. Maingon, F. Bonnetain, 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Chemotherapy with Preoperative Radiotherapy in Rectal Cancer

L. Collette, G. Calais, J. Bosset, 2007 .

Pattern of occult nodal relapse diagnosed with (18)F-fluoro-choline PET/CT in prostate cancer patients with biochemical failure after prostate-only radiotherapy.

J. Bosset, P. Maingon, F. Brunotte, 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Internal Mammary and Medial Supraclavicular Irradiation in Breast Cancer.

E. van Limbergen, I. Barillot, S. Marnitz, 2015, The New England journal of medicine.

Delineation of the neck node levels for head and neck tumors: a 2013 update. DAHANCA, EORTC, HKNPCSG, NCIC CTG, NCRI, RTOG, TROG consensus guidelines.

K. Ang, V. Grégoire, B. O'Sullivan, 2014, Radiotherapy and Oncology.

Osteosarcomas of the mandible: multidisciplinary management of a rare tumor of the young adult a cooperative study of the GSF-GETO, Rare Cancer Network, GETTEC/REFCOR and SFCE.

A. Italiano, J. Thariat, P. Maingon, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Improved Outcome by Adding Concurrent Chemotherapy to Cetuximab and Radiotherapy for Locally Advanced Head and Neck Carcinomas: Results of the GORTEC 2007-01 Phase III Randomized Trial.

J. Bourhis, C. Borel, P. Maingon, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Predictive value of health-related quality of life on radiotherapy-related toxicities in patients with head and neck cancer

P. Maingon, F. Bonnetain, S. Maillard, 2023, Supportive Care in Cancer.

Outcome impact and cost-effectiveness of quality assurance for radiotherapy planned for the EORTC 22071-24071 prospective study for head and neck cancer.

V. Grégoire, C. Combescure, L. Peters, 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Exclusive radiotherapy for inoperable stage I Non Small Cell Lung Cancer (NSCLC): A multicentric study

P. Houtte, J. Bosset, P. Maingon, 2000 .